A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells

被引:226
作者
Luo, Y
Ziebell, MR
Prestwich, GD
机构
[1] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA
[2] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA
关键词
D O I
10.1021/bm000283n
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A cell-targeted polymeric prodrug prepared from Taxol and chemically modified hyaluronic acid (HA) was evaluated in vitro. Herein we report four results in support of the selective uptake and targeted toxicity of the HA-Taxol prodrug. First, a fluorescently labeled HA-Taxol (FITC-HA-Taxol) was synthesized and used to demonstrate cell-specific binding and uptake using flow cytometry and confocal microscopy. Second, the selective cytotoxicity of FITC-HA-Taxol allowed direct correlation of uptake with selective cytotoxicity. Third, the rapid uptake and selective cytotoxicity of HA-Taxol bioconjugates could be blocked by either excess HA or by an anti-CD44 antibody, but not by chondroitin sulfate (CS), Finally, the release of free Taxol From HA-Taxol in human plasma or in cell culture media revealed that the free drug was hydrolytically released from the bioconjugate by cleavage of the labile 2' ester linkage. Taken together, these data support the notion that the targeted cytotoxicity of HA-Taxol bioconjugates requires receptor-mediated cellular uptake of the bioconjugate followed by hydrolytic release of free Taxol.
引用
收藏
页码:208 / 218
页数:11
相关论文
共 64 条
[1]   Evaluation of antitumor activities of hyaluronate binding antitumor drugs: Synthesis, characterization and antitumor activity [J].
Akima, K ;
Ito, H ;
Iwata, Y ;
Matsuo, K ;
Watari, N ;
Yanagi, M ;
Hagi, H ;
Oshima, K ;
Yagita, A ;
Atomi, Y ;
Tatekawa, I .
JOURNAL OF DRUG TARGETING, 1996, 4 (01) :1-&
[2]   ANGIOSTASIS AND VASCULAR REGRESSION IN CHRONIC GRANULOMATOUS INFLAMMATION-INDUCED BY DICLOFENAC IN COMBINATION WITH HYALURONAN IN MICE [J].
ALAM, CAS ;
SEED, MP ;
WILLOUGHBY, DA .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1995, 47 (05) :407-411
[3]   ALBUMIN MICROSPHERES AND MICROCAPSULES - METHODOLOGY OF MANUFACTURING TECHNIQUES [J].
ARSHADY, R .
JOURNAL OF CONTROLLED RELEASE, 1990, 14 (02) :111-131
[4]  
ASPLUND T, 1994, CANCER RES, V54, P4516
[5]   Interaction between the adhesion receptor, CD44, and the oncogene product, p185(HER2), promotes human ovarian tumor cell activation [J].
Bourguignon, LYW ;
Zhu, HB ;
Chu, A ;
Iida, N ;
Zhang, L ;
Hung, MC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (44) :27913-27918
[6]  
CARTLIDGE S A, 1987, Journal of Controlled Release, V4, P265, DOI 10.1016/0168-3659(87)90018-6
[7]   INCREASED EXPRESSION OF CD44 IN BOVINE ARTICULAR CHONDROCYTES BY CATABOLIC CELLULAR MEDIATORS [J].
CHOW, G ;
KNUDSON, CB ;
HOMANDBERG, G ;
KNUDSON, W .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) :27734-27741
[8]   Rapid hyaluronan uptake is associated with enhanced motility: implications for an intracellular mode of action [J].
Collis, L ;
Hall, C ;
Lange, L ;
Ziebell, M ;
Prestwich, R ;
Turley, EA .
FEBS LETTERS, 1998, 440 (03) :444-449
[9]   BINDING AND DEGRADATION OF HYALURONAN BY HUMAN BREAST-CANCER CELL-LINES EXPRESSING DIFFERENT FORMS OF CD44 - CORRELATION WITH INVASIVE POTENTIAL [J].
CULTY, M ;
SHIZARI, M ;
THOMPSON, EW ;
UNDERHILL, CB .
JOURNAL OF CELLULAR PHYSIOLOGY, 1994, 160 (02) :275-286
[10]   THE HYALURONAN RECEPTOR (CD44) PARTICIPATES IN THE UPTAKE AND DEGRADATION OF HYALURONAN [J].
CULTY, M ;
NGUYEN, HA ;
UNDERHILL, CB .
JOURNAL OF CELL BIOLOGY, 1992, 116 (04) :1055-1062